ITGAM and neoplasm: The phenotype of MDSCs described in different tumor models is based upon their expression of one or more myeloid markers including the β2 integrin CD11b [3], MCSF-R [4], CD124 [5], and the two epitopes of the myeloid marker GR-1, Ly6C [6] and Ly6G [7].